TL;DR
- What was at stake
- The agency needed to win and keep regulated pharma and banking clients, and to run studies faster and for less.
- What changed
- Studies drew from the agency’s own panel instead of third-party vendors.
- My role
- Researcher and panel architect. I designed the panel solo and built it primarily on my own.
- Timeline
- About a year
External recruitment spend, down from vendor rates on every study that needed screened participants.
Less recruitment time per study, because participants were already on hand.
About 1,000 opted-in participants, each with a traceable source and consent record, used for studies for Pfizer, Eli Lilly, Merck, J&J, AbbVie, M&T Bank, and others.
Read the full case study
An opt-in, a referral program, and compliance from day one
Built in Qualtrics. People who finished a study got a clear invitation to join the panel, kept separate from the study itself. Joining was never a condition of finishing.
Each member got a unique code, and attribution logic I designed tied every new participant to their source. Rewards ran through Amazon at first, then Giftbit.
It shaped every data handling decision from the first plan on. Participant data lived in Azure SQL.
Buy a list, or build from opt-ins
Buy email lists.
Volume sooner. A purchased list doesn’t show where anyone came from or whether they agreed to be contacted.
Build it from people who chose to join.
Slower to start, with proof of where every participant came from.
My manager was adamant from the start that we would buy email lists and had a hard time letting that go. I knew during the research phase I wouldn’t, and I raised it once the intake survey was built and we were close to fielding, so I had a working alternative to show. My manager came around.
Regulated clients and no panel of our own
Crowley Webb is an advertising agency that also owns Praxis, a clinical trial recruitment firm, and I worked for both. Praxis brought the pharma relationships, and the agency had banking clients too. Every study that needed screened participants went to a third-party vendor, which meant paying vendor rates on top of the research and accepting whatever panel quality they offered.
Research and compliance came first
How panels get built, from people who had built them.
Recruitment, consent, and storage, approved before any build.
Built with legal and compliance. The survey carried heavy branching logic.
Reached ~1,000 participants.
Research, planning, approval, and compliance took almost half the year before anyone could join, which is why growth started slow.
Impact
Building the panel from scratch convinced me that consent and compliance have to be designed in from the start. For the agency, studies could move at the pace pharma and banking clients expected, with participants we could vouch for.
Hindsight
I documented as I went, but around my own workflow. A playbook someone else could run would have made the panel easier to hand off and extend without me.The panel could have kept growing after I left for Isobar.
Recruitment got the attention because that’s where the pressure was. Re-engagement for inactive members and a refresh plan were handled as they came up. Designing them in from the start would have cut attrition and kept the panel’s makeup cleaner.
With two more weeks
Check response rates, completion, and screener pass rates for opt-in members against referrals.
Run the same screener on both and compare quality and cost directly.
Turn $0 in external recruitment spend into a dollar figure based on past vendor rates.